March 3, 2017 / 12:12 PM / 9 months ago

BRIEF-Reata Pharmaceuticals reports Q4 loss per share $0.19

March 3 (Reuters) - Reata Pharmaceuticals Inc

* Reata Pharmaceuticals Inc. announces fourth quarter and full year 2016 financial and operating results

* Q4 loss per share $0.19

* Q4 earnings per share view $-0.15 -- Thomson Reuters I/B/E/S

* Qtrly total collaboration revenue $12.5 million versus $12.53 million Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below